Cullinan Therapeutics, Inc. (CGEM)
14.70
-0.28
(-1.90%)
USD |
NASDAQ |
May 07, 16:00
14.70
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Market Cap : 890.04M for May 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 166.62B |
| Elevance Health, Inc. | 80.97B |
| Nkarta, Inc. | 224.21M |
| Janux Therapeutics, Inc. | 885.71M |
| Zenas BioPharma, Inc. | 1.197B |
Market Cap Related Metrics
| PEG Ratio | -0.2106 |
| Price to Book Value | 2.178 |
| Price | 14.70 |
| Earnings Yield | -25.32% |
| PEGY Ratio | -0.2106 |